首页> 外文期刊>Journal of Medicinal Chemistry >Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission.
【24h】

Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission.

机译:HIV和其他病毒的聚阴离子抑制剂。 7.衍生自环糊精的聚阴离子化合物和聚两性离子化合物,作为HIV传播的抑制剂。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

New polyanionic compounds were obtained from radical addition of thiomalic acid and mercaptopropionic acid onto perallylated cyclodextrins (CDs) under UV irradiation with a catalytic amount of alpha,alpha'-azobis(isobutyronitrile). All these polyanions, bearing 18-48 carboxylate groups, inhibited human immunodeficiency virus type 1 (HIV-1) strain IIIB replication in MT-4 cells at a 50% inhibitory concentration (IC50) of 0.1-2.9 microM, while not being toxic to the host cells at concentrations up to 62 microM. These compounds were also active against a clinical HIV-1 isolate (HE) at >/=4-fold higher concentrations. Only some compounds showed activity against the two HIV-2 strains (ROD and EHO) but at higher concentrations than those required to inhibit HIV-1 (IIIB and HE) replication. In addition, these compounds were not active against the M-tropic HIV-1 strain BaL but were active against simian immunodeficiency virus [SIV (MAC251)]. These compounds were also inhibitory to the replication of human cytomegalovirus at an IC50 of 1-10 microM, but not herpes simplex virus (type 1 and type 2) or other (picorna-, toga-, reo-, orthomyxo-, paramyxo-, bunya-, rhabdo-, and poxvirus) viruses. Radical addition on perallylated CDs of a protected cysteine gave polyzwitterionic compounds. None of these last compounds proved inhibitory to the replication of HIV-1, HIV-2, or any of the other viruses tested.
机译:通过在催化量的α,α'-偶氮二(异丁腈)的紫外线辐射下,将硫代苹果酸和巯基丙酸自由基加成到高丙基化环糊精(CD)上,可以得到新的聚阴离子化合物。所有这些带有18-48个羧酸根的聚阴离子均以0.1-2.9 microM的50%抑制浓度(IC50)抑制MT-4细胞中的人类免疫缺陷病毒1型(HIV-1)IIIB株复制。宿主细胞的浓度可达62 microM。这些化合物还对临床HIV-1分离株(HE)具有高> / = 4倍的浓度。只有某些化合物显示出对两种HIV-2菌株(ROD和EHO)的活性,但其浓度高于抑制HIV-1(IIIB和HE)复制所需的浓度。此外,这些化合物对M-tropic HIV-1株BaL没有活性,但对猿猴免疫缺陷病毒[SIV(MAC251)]有活性。这些化合物还以1-10 microM的IC50抑制人巨细胞病毒的复制,但不抑制单纯疱疹病毒(1型和2型)或其他(picorna-,toga-,reo-,orthomyxo-,paramyxo-,布尼亚病毒,弹状病毒和痘病毒)。在被保护的半胱氨酸的高allylated CD上自由基加成得到多性两性离子化合物。这些最后的化合物均未证明可抑制HIV-1,HIV-2或任何其他测试的病毒的复制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号